Reduction of heart rate and beta-blocker applications by biofeedback in performing elective CT coronary angiography.

Reduction of heart rate and beta-blocker applications by biofeedback in performing elective CT coronary angiography. - biofeedback

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00019192

Enrollment

Registered

2019-11-04

Start date

2019-11-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease (CHD) I20-I25

Interventions

Group 1: Patients receive elective CT coronary angiography to exclude CHD, with biofeedback. Group 2: Patients receive elective CT coronary angiography to exclude CHD, without biofeedback.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing elective CT coronary angiography to exclude coronary heart disease.

Exclusion criteria

Exclusion criteria: Patient denied participation in the study.

Design outcomes

Primary

Measure	Time frame
The aim of this study is the reduction of the heart rate by using biofeedback within a routine CT coronary angiography.	—

Secondary

Measure	Time frame
The aim of this study is the reduction of the commonly used ß-blocker-doses within a routine CT coronary angiography.	—

Countries

Germany

Contacts

Public ContactAnnett Lebenatus

Universitätsklinikum Schleswig-Holstein, Campus KielRadiologie und Neuroradiologie

annett.lebenatus@uksh.de0431 50016570

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026